NSCLC Adjuvant Targeted Therapy

Sort by:
Relevance Thumbs Up Comments Views Newest Oldest
07:37

MI&T Congressi

How to Select EGFR-Mutated Patients for EGFR+CT Combo in NSCLC

FEATURING Pasi Janne
  • 176 views
  • July 26, 2024
  • 2
08:18

MI&T Congressi

ADC in Combination With Immunotherapy for NSCLC

FEATURING Stephen Liu
  • 224 views
  • July 26, 2024
  • 1
10:58

MI&T Congressi

Therapies for ROS1+ NSCLC

FEATURING Lorenza Landi
  • 91 views
  • July 24, 2024
08:17

MI&T Congressi

Options for NTRK Rearranged NSCLC

FEATURING Roberto Ferrara
  • 68 views
  • July 24, 2024
07:55

MI&T Congressi

MET Exon 14 Skipping Mutations in NSCLC

FEATURING Oliver Gautschi
  • 200 views
  • July 19, 2024
  • 1
10:50

MI&T Congressi

Current ADC Development in NSCLC

FEATURING Hossein Borghaei
  • 189 views
  • July 18, 2024
  • 2
12:06

MI&T Congressi

KRAS Inhibitors for Lung Cancer

FEATURING Rafael Rosell
  • 217 views
  • July 16, 2024
  • 2
16:52

Martin Dietrich

Biomarker Testing in NSCLC

  • 463 views
  • July 16, 2024
  • 4
15:31

Shivaani Kummar

Clinical Implications of Tumor Agnostic Therapies

  • 337 views
  • July 12, 2024
  • 3
09:12

MI&T Congressi

How the Experts Treat: Neoadjuvant or Adjuvant Targeted Therapy in Resectable Oncogene-Addicted NSCLC

FEATURING Jarushka Naidoo
  • 167 views
  • July 12, 2024
  • 2
04:08

COR2ED The Heart of Medical Education

ASCO® 2024 Summary: "The Latest Data in Oncogene-Addicted NSCLC"

FEATURING Nicolas Girard
  • 201 views
  • July 11, 2024
  • 1
40:00

ecancer

ASCO® 2024: Highlights and Analysis of Key Solid Cancer Trials

FEATURING Bishal Gyawali
  • 105 views
  • July 2, 2024
  • 1
05:26

ecancer

ASCO® 2024 Lung Cancer Updates: CROWN, ADRIATIC, and LAURA Trials

FEATURING Luis Raez
  • 69 views
  • July 2, 2024
  • 1
03:04

ecancer

ASCO® 2024 Insights: "HARMONi-A Study - Ivonescimab + Chemo for EGFRm NSCLC Patients Who Progressed on EGFR-TKI Treatment"

FEATURING Li Zhang
  • 33 views
  • July 2, 2024
  • 1
19:33

ecancer

ASCO® 2024 Lung Cancer Roundtable: Advances in NSCLC

FEATURING Enriqueta Felip, Alex Spira, Antonio Passaro, Alfredo Addeo
  • 563 views
  • June 21, 2024
  • 2
12:19

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "TROPION-Lung05 Study - Intracranial Efficacy of Dato-DXd in Patients With Previously Treated Advanced/Metastatic NSCLC With Actionable Genomic Alterations"

FEATURING Aaron Lisberg
  • 200 views
  • June 21, 2024
  • 2
36:14

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Lung Cancer Highlights: Top Abstracts Including BEAT-SC, ADRIATIC, KRYSTAL-12, and LAURA Trials

FEATURING Balazs Halmos
  • 930 views
  • June 21, 2024
  • 11
02:26

ecancer

ASCO® 2024 Insights: "KRYSTAL-12 Study - Adagrasib vs. Docetaxel in Patients With Previously Treated Advanced/Metastatic NSCLC Harboring a KRASG12C Mutation"

FEATURING Robert Jotte
  • 194 views
  • June 21, 2024
  • 2
09:42

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "HARMONi-A Trial - Ivonescimab Combined With Chemo in Patients With EGFRm non-Squamous NSCLC Who Progressed on EGFR-TKI Treatment"

FEATURING Li Zhang
  • 131 views
  • June 17, 2024
  • 1
16:16

Lorenzo Belluomini

Clinical Insights on the Management of Edema Associated With MET Inhibitors in NSCLC

  • 240 views
  • June 17, 2024
  • 1
16:10

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Lung Cancer Highlights: CROWN, LAURA, ADRIATIC, and PALOMA-3 Trials

FEATURING Luis Raez
  • 735 views
  • June 14, 2024
  • 5
06:53

2024 ASCO® Annual Meeting Insights Hub

Impact on Biomarker Documentation in Community Oncology by Optimizing Clinical Decision Support for adjNSCLC, mNSCLC, and mCRPC

FEATURING Daniel Rubin
  • 315 views
  • June 13, 2024
11:45

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "KRYSTAL-12 Study - Adagrasib vs. Docetaxel in Patients With Previously Treated Advanced/Metastatic NSCLC Harboring KRASG12C Mutations"

FEATURING Tony Mok
  • 458 views
  • June 13, 2024
  • 1
07:06

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "RAGNAR Trial - Erdafitinib Efficacy & Safety in Advanced NSCLC With FGFR Alterations"

FEATURING Martin Schuler
  • 135 views
  • June 6, 2024
  • 1
23:25

COR2ED The Heart of Medical Education

Perseverance in NSCLC Molecular Testing Pays Off: Looking Beyond the Obvious Mutations

FEATURING Mark Socinski, Frédérique Penault-Llorca
  • 68 views
  • May 29, 2024
  • 1

NSCLC Adjuvant Targeted Therapy

No subtopics